| 摘要 |
<p>The methods described herein provide treatment of glaucoma, ocular hypertension, and elevated intraocular pressure with latanoprostlatanoprost or anotherlatanoprost or therapeutic agentother therapeutic agent(s). Implant devices for insertion into a punctum of a patient provide sustained release of latanoprostlatanoprost or anotherlatanoprost or therapeutic agentother therapeutic agent(s) that is maintained for 7, 14, 21, 30, 45, 60, or 90 days or more, thus avoiding patient noncompliance and reducing or lowering adverse events associated with eye drop administration of latanoprostlatanoprost or other therapeutic agentother therapeutic agent(s) and other therapeutic agentother therapeutic agent(s)s.</p> |
